Treatment of childhood obesity

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 15, Issue 1, 2008, Pages 37-47

  Uli, Naveen ^a   Sundararajan, Sumana ^a   Cuttler, Leona ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Adolescents; Children; Obesity; Policy; Treatment

Indexed keywords

ALLI; AMFEBUTAMONE; EXENDIN 4; METFORMIN; PLACEBO; RECOMBINANT LEPTIN; RIMONABANT; SIBUTRAMINE; TETRAHYDROLIPSTATIN; TOPIRAMATE; UNCLASSIFIED DRUG; ZONISAMIDE;

BARIATRIC SURGERY; BEHAVIOR CHANGE; BEHAVIOR THERAPY; CHILD; CHILDHOOD DISEASE; CLINICAL TRIAL; CONSTIPATION; DIARRHEA; DRUG CONTRAINDICATION; DRUG INDICATION; FECES COMPOSITION; FLATULENCE; HEADACHE; HEALTH CARE POLICY; HUMAN; HYPERTENSION; INCONTINENCE; INSOMNIA; LACTIC ACIDOSIS; LIFESTYLE MODIFICATION; MORBID OBESITY; NAUSEA; OBESITY; OILY FECES; OUTCOME ASSESSMENT; PATIENT SELECTION; PRACTICE GUIDELINE; PRIMARY PREVENTION; REVIEW; RISK REDUCTION; SIDE EFFECT; TACHYCARDIA; TREATMENT INDICATION; TREATMENT PLANNING; VITAMIN DEFICIENCY; VOMITING; WEIGHT REDUCTION; XEROSTOMIA;

BARIATRIC SURGERY; CHILD; COMBINED MODALITY THERAPY; COUNSELING; DIET THERAPY; DRUG THERAPY; EXERCISE THERAPY; HEALTH PLANNING GUIDELINES; HEALTH POLICY; HUMANS; OBESITY;

EID: 38049110623     PISSN: 1752296X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MED.0b013e3282f41d6a     Document Type: Review

References (94)

1. Ogden CL, Carroll MD, Curtin LR, et al. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006; 295:1549-1555.
2. Speiser PW, Rudolf MC, Anhalt H, et al. Childhood obesity. J Clin Endocrinol Metab 2005; 90:1871-1887.
3. Marshall SJ, Biddle SJ, Gorely T, et al. Relationships between media use, body fatness and physical activity in children and youth: a meta-analysis. Int J Obes Relat Metab Disord 2004; 28:1238-1246.
4. Dietz WH Jr, Gortmaker SL. Do we fatten our children at the television set? Obesity and television viewing in children and adolescents. Pediatrics 1985; 75:807-812.
5. Hills AP, King NA, Armstrong TP. The contribution of physical activity and sedentary behaviours to the growth and development of children and adolescents: implications for overweight and obesity. Sports Med 2007; 37:533-545.
6. American Academy of Pediatrics CoPE. Children, Adolescents and Television. Pediatrics 2001; 107:423-426.
7. Bowman SA, Gortmaker SL, Ebbeling CB, et al. Effects of fast-food consumption on energy intake and diet quality among children in a national household survey. Pediatrics 2004; 113 (1 Pt 1):112-118.
8. Institute of Medicine of the National Academies. Preventing Childhood Obesity: Health in the Balance. Washington, DC: National Academies Press; 2005.
9. Whitaker RC, Wright JA, Pepe MS, et al. Predicting obesity in young adulthood from childhood and parental obesity. N Engl J Med 1997; 337:869-873.
10. Swallen KC, Reither EN, Haas SA, Meier AM. Overweight, obesity, and health-related quality of life among adolescents: the National Longitudinal Study of Adolescent Health. Pediatrics 2005; 115:340-347.
11. Williams J, Wake M, Hesketh K, et al. Health-related quality of life of overweight and obese children. JAMA 2005; 293:70-76.
12. Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 2002; 165:1217-1239.
13. Rosenfield RL. Clinical review: Identifying children at risk for polycystic ovary syndrome. J Clin Endocrinol Metab 2007; 92:787-796.
14. Artz E, Haqq A, Freemark M. Hormonal and metabolic consequences of childhood obesity. Endocrinol Metab Clin North Am 2005; 34:643-658; ix.
15. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report. National Institutes of Health. Obes Res 1998; 6(Suppl 2):51S-209S.
16. Fontaine KR, Redden DT, Wang C, et al. Years of life lost due to obesity. JAMA 2003; 289:187-193.
17. Cuttler L, Whittaker JL, Kodish ED. The overweight adolescent: clinical and ethical issues in intensive treatments for pediatric obesity. J Pediatr 2005; 146:559-564.
18. Cuttler L, Whittaker JL, Kodish ED. Pediatric obesity policy: the danger of skepticism. Arch Pediatr Adolesc Med 2003; 157:722-724.
19. US Department of Health and Human Services. The Surgeon General's call to action to prevent and decrease overweight and obesity: overweight in children and adolescents. www.surgeongeneral.gov/topics/obesity/calltoaction/ fact_adolescents.htm. [Accessed 30 October 2007]
20. Sturm R. The effects of obesity, smoking, and drinking on medical problems and costs. Health Aff (Millwood) 2002; 21:245-253.
21. Wang G, Dietz WH. Economic burden of obesity in youths aged 6 to 17 years: 1979-1999. Pediatrics 2002; 109:E81-E181.
22. Ferguson MA, Gutin B, Le NA, et al. Effects of exercise training and its cessation on components of the insulin resistance syndrome in obese children. Int J Obes Relat Metab Disord 1999; 23:889-895.
23. Dekker MJ, Lee S, Hudson R, et al. An exercise intervention without weight loss decreases circulating interleukin-6 in lean and obese men with and without type 2 diabetes mellitus. Metabolism 2007; 56:332-338.
24. Balagopal P, George D, Patton N, et al. Lifestyle-only intervention attenuates the inflammatory state associated with obesity: a randomized controlled study in adolescents. J Pediatr 2005; 146:342-348.
25. Gibson LJ, Peto J, Warren JM, dos Santos Silva I. Lack of evidence on diets for obesity for children: a systematic review. Int J Epidemiol 2006; 35:1544-1552. Systematic comparison of diets for youth.
26. Malik VS, Hu FB. Popular weight-loss diets: from evidence to practice. Nat Clin Pract Cardiovasc Med 2007; 4:34-41.
27. Epstein LH, Wing RR, Valoski A. Childhood obesity. Pediatr Clin North Am 1985; 32:363-379.
28. Epstein LH, Valoski A, Wing RR, McCurley J. Ten-year follow-up of behavioral, family-based treatment for obese children. JAMA 1990; 264: 2519-2523.
29. Epstein LH, Wing RR, Penner BC, Kress MJ. Effect of diet and controlled exercise on weight loss in obese children. J Pediatr 1985; 107:358-361.
30. Ornish D. Every Day Cooking with Dean Ornish. New York: Harper Collins; 1997.
31. Willett WC. Dietary fat plays a major role in obesity: no. Obes Rev 2002; 3:59-68.
32. Sondike SB, Copperman N, Jacobson MS. Effects of a low-carbohydrate diet on weight loss and cardiovascular risk factor in overweight adolescents. J Pediatr 2003; 142:253-258.
33. Steward L. The New Sugar Busters! Cut Sugar to Trim Fat. New York: Ballantine Publishing Group; 2003.
34. Atkins R. Dr Atkins' new Diet Revolution. New York: Avon Books; 1998.
35. Sears B. A Dietary Road Map to Lose Weight Permanently. New York: Harper Collins; 2003.
36. Gardner CD, Kiazand A, Alhassan S, et al. Comparison of the Atkins, Zone, Ornish, and LEARN diets for change in weight and related risk factors among overweight premenopausal women: the A TO Z Weight Loss Study: a randomized trial. JAMA 2007; 297:969-977.
37. Nordmann AJ, Nordmann A, Briel M, et al. Effects of low-carbohydrate vs low-fat diets on weight loss and cardiovascular risk factors: a meta-analysis of randomized controlled trials. Arch Intern Med 2006; 166:285-293. Meta-analysis of randomized controlled trials comparing low-carbohydrate and low-fat diets in adults.
38. Ebbeling CB, Leidig MM, Sinclair KB, et al. A reduced-glycemic load diet in the treatment of adolescent obesity. Arch Pediatr Adolesc Med 2003; 157:773-779.
39. Ludwig DS. Clinical update: the low-glycaemic-index diet. Lancet 2007; 369:890-892.
40. McMillan-Price J, Petocz P, Atkinson F, et al. Comparison of 4 diets of varying glycemic load on weight loss and cardiovascular risk reduction in overweight and obese young adults: a randomized controlled trial. Arch Intern Med 2006; 166:1466-1475.
41. Archibald EH, Harrison JE, Pencharz PB. Effect of a weight-reducing high-protein diet on the body composition of obese adolescents. Am J Dis Child 1983; 137:658-662.
42. Merritt RJ, Bistrian BR, Blackburn GL, Suskind RM. Consequences of modified fasting in obese pediatric and adolescent patients. I. Protein-sparing modified fast. J Pediatr 1980; 96:13-19.
43. Figueroa-Colon R, von Almen TK, Franklin FA, et al. Comparison of two hypocaloric diets in obese children. Am J Dis Child 1993; 147:160-166.
44. Michiel RR, Sneider JS, Dickstein RA, et al. Sudden death in a patient on a liquid protein diet. N Engl J Med 1978; 298:1005-1007.
45. Sours HE, Frattali VP, Brand CD, et al. Sudden death associated with very low calorie weight reduction regimens. Am J Clin Nutr 1981; 34:453-461.
46. Stallings VA, Archibald EH, Pencharz PB. Potassium, magnesium, and calcium balance in obese adolescents on a protein-sparing modified fast. Am J Clin Nutr 1988; 47:220-224.
47. Collins CE, Warren J, Neve M, et al. Measuring effectiveness of dietetic interventions in child obesity: a systematic review of randomized trials. Arch Pediatr Adolesc Med 2006; 160:906-922.
48. Golan M, Crow S. Targeting parents exclusively in the treatment of childhood obesity: long-term results. Obes Res 2004; 12:357-361.
49. Wilfley DE, Tibbs TL, Van Buren DJ, et al. Lifestyle interventions in the treatment of childhood overweight: a meta-analytic review of randomized controlled trials. Health Psychol 2007; 26:521-532. This excellent meta-analysis based on rigorous controlled trials provides evidence for the short-term efficacy of lifestyle interventions in managing childhood obesity.
50. Savoye M, Shaw M, Dziura J, et al. Effects of a weight management program on body composition and metabolic parameters in overweight children: a randomized controlled trial. JAMA 2007; 297:2697-2704. One-year randomized controlled trial showing beneficial effects of lifestyle intervention on body composition and insulin resistance.
51. Balagopal P, Graham TE, Kahn BB, et al. Reduction of elevated serum retinol binding protein in obese children by lifestyle intervention: association with subclinical inflammation. J Clin Endocrinol Metab 2007; 92:1971-1974.
52. Wilfley DE, Stein RI, Saelens BE, et al. Efficacy of maintenance treatment approaches for childhood overweight: a randomized controlled trial. JAMA 2007; 298:1661-1673. Provides evidence that short-term weight loss may be sustained for up to 2 years with the addition of behavioral skills or social facilitation maintenance treatment.
53. Dreimane D, Safani D, MacKenzie M, et al. Feasibility of a hospital-based, family-centered intervention to reduce weight gain in overweight children and adolescents. Diabetes Res Clin Pract 2007; 75:159-168.
54. Dunican KC, Desilets AR, Montalbano JK. Pharmacotherapeutic options for overweight adolescents. Ann Pharmacother 2007; 41:1445-1455. Comprehensive summary of adolescent trials of orlistat, sibutramine, and metformin, with updated FDA guidelines on their use.
55. Freemark M. Pharmacotherapy of childhood obesity: an evidence-based, conceptual approach. Diabetes Care 2007; 30:395-402. Excellent review of available evidence of the benefits and risks of currently available medications. Provides key insights and conceptualizations of pharmacologic approach to childhood obesity.
56. Chanoine JP, Hampl S, Jensen C, et al. Effect of orlistat on weight and body composition in obese adolescents: a randomized controlled trial. JAMA 2005; 293:2873-2883.
57. Ozkan B, Bereket A, Turan S, Keskin S. Addition of orlistat to conventional treatment in adolescents with severe obesity. Eur J Pediatr 2004; 163:738-741.
58. Norgren S, Danielsson P, Jurold R, et al. Orlistat treatment in obese prepubertal children: a pilot study. Acta Paediatr 2003; 92:666-670.
59. McDuffie JR, Calis KA, Uwaifo GI, et al. Three-month tolerability of orlistat in adolescents with obesity-related comorbid conditions. Obes Res 2002; 10:642-650.
60. Garcia-Morales LM, Berber A, Macias-Lara CC, et al. Use of sibutramine in obese mexican adolescents: a 6-month, randomized, double-blind, placebo-controlled, parallel-group trial. Clin Ther 2006; 28:770-782.
61. Violante-Ortiz R, Del-Rio-Navarro BE, Lara-Esqueda A, et al. Use of sibutramine in obese Hispanic adolescents. Adv Ther 2005; 22:642-649.
62. Godoy-Matos A, Carraro L, Vieira A, et al. Treatment of obese adolescents with sibutramine: a randomized, double-blind, controlled study. J Clin Endocrinol Metab 2005; 90:1460-1465.
63. Berkowitz RI, Wadden TA, Tershakovec AM, Cronquist JL. Behavior therapy and sibutramine for the treatment of adolescent obesity: a randomized controlled trial. JAMA 2003; 289:1805-1812.
64. Berkowitz RI, Fujioka K, Daniels SR, et al. Effects of sibutramine treatment in obese adolescents: a randomized trial. Ann Intern Med 2006; 145:81-90. Largest randomized controlled trial of sibutramine in obese adolescents to date.
65. Beaston P. Clinical Review for NDA 20-632, SE5-021. 2007. www.fda.gov/cder/foi/esum/2005/ 020632s021_sibutramine_hydrochloride_Clinical_BPCA.pdf. [Accessed 30 October 2007]
66. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346:393-403.
67. Srinivasan S, Ambler GR, Baur LA, et al. Randomized, controlled trial of metformin for obesity and insulin resistance in children and adolescents: improvement in body composition and fasting insulin. J Clin Endocrinol Metab 2006; 91:2074-2080.
68. Freemark M, Bursey D. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes. Pediatrics 2001; 107:E55.
69. Kay JP, Alemzadeh R, Langley G, et al. Beneficial effects of metformin in normoglycemic morbidly obese adolescents. Metabolism 2001; 50:1457-1461.
70. Yanovski JA. Intensive therapies for pediatric obesity. Pediatr Clin North Am 2001; 48:1041-1053.
71. Lustig RH, Hinds PS, Ringwald-Smith K, et al. Octreotide therapy of pediatric hypothalamic obesity: a double-blind, placebo-controlled trial. J Clin Endocrinol Metab 2003; 88:2586-2592.
72. Gibson WT, Farooqi IS, Moreau M, et al. Congenital leptin deficiency due to homozygosity for the Delta133G mutation: report of another case and evaluation of response to four years of leptin therapy. J Clin Endocrinol Metab 2004; 89:4821-4826.
73. Pi-Sunyer FX, Aronne LJ, Heshmati HM, et al. Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial. JAMA 2006; 295:761-775.
74. DeMaria EJ. Bariatric surgery for morbid obesity. N Engl J Med 2007; 356:2176-2183.
75. Gastrointestinal surgery for severe obesity: National Institutes of Health Consensus Development Conference Statement. Am J Clin Nutr 1992; 55(Suppl 2):615S-619S.
76. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004; 292:1724-1737.
77. McMahon MM, Sarr MG, Clark MM, et al. Clinical management after bariatric surgery: value of a multidisciplinary approach. Mayo Clin Proc 2006; 81 (10 Suppl):S34-S45.
78. Stocker DJ. Management of the bariatric surgery patient. Endocrinol Metab Clin North Am 2003; 32:437-457.
79. Kaplan LM. Gastrointestinal management of the bariatric surgery patient. Gastroenterol Clin North Am 2005; 34:105-125.
80. Maggard MA, Shugarman LR, Suttorp M, et al. Meta-analysis: surgical treatment of obesity. Ann Intern Med 2005; 142:547-559.
81. Lawson ML, Kirk S, Mitchell T, et al. One-year outcomes of Roux-en-Y gastric bypass for morbidly obese adolescents: a multicenter study from the Pediatric Bariatric Study Group. J Pediatr Surg 2006; 41:137-143; discussion 137-143.. One of the first papers systematically analyzing outcomes for bariatric surgery in adolescents.
82. Apovian CM, Baker C, Ludwig DS, et al. Best practice guidelines in pediatric/adolescent weight loss surgery. Obes Res 2005; 13:274-282.
83. Xanthakos SA, Daniels SR, Inge TH. Bariatric surgery in adolescents. Adolesc Med 2006; 17:589-612.
84. Nader PR, O'Brien M, Houts R, et al. Identifying risk for obesity in early childhood. Pediatrics 2006; 118:e594-e601.
85. AAP. Available at: www.aap.org/obesity/Publications.htm. [Accessed 30 October 2007]
86. NICHQ. Available at: www.nichq.org/NICHQ/Programs/ConferencesAnd- Training/ChildhoodObesityActionNetwork.htm. [Accessed 30 October 2007]
87. Expert Committee Recommendations on the Assessment, Prevention, and treatment of Child and Adolescent Overweight and Obesity; 2007. www.ama-assn.org/ama1/pub/upload/mm/433/ped_obesity_recs.pdf. [Accessed 30 October 2007] Provides updated definition of overweight and obesity. Also provides staged approach to management and specific weight loss goals for various age groups and BMI categories in children.
88. Dietary Guidelines for Americans; 2005. www.health.gov/dietaryguidelines/ dga2005/document/pdf/DGA2005.pdf. [Accessed 30 October 2007]
89. Zhou G, Myers R, Li Y, et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 2001; 108:1167-1174.
90. Lindsay JR, Duffy NA, McKillop AM, et al. Inhibition of dipeptidyl peptidase IV activity by oral metformin in Type 2 diabetes. Diabet Med 2005; 22:654-657.
91. English PJ, Ashcroft A, Patterson M, et al. Metformin prolongs the postprandial fall in plasma ghrelin concentrations in type 2 diabetes. Diabetes Metab Res Rev 2007; 23:299-303.
92. Zelber-Sagi S, Kessler A, Brazowskyn E, et al. A double-blind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2006; 4:639-644.
93. Bugianesi E, Gentilcore E, Manini R, et al. A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease. Am J Gastroenterol 2005; 100:1082-1090.
94. Barlow SE, Dietz WH. Obesity evaluation and treatment: Expert Committee recommendations. Pediatrics 1998; 102:e29.